New radiation technique may improve cancer control in advanced head and neck cancer
NCT ID NCT06641791
First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times
Summary
This study compares a newer, precise radiation method called stereotactic body radiotherapy (SBRT) with standard radiation therapy for people with advanced head and neck cancer who cannot have curative treatment. About 196 adults will be randomly assigned to one of the two radiation approaches. The main goal is to see if SBRT helps people live longer and better controls the cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Arthur J.E. Child Comprehensive Cancer Centre
RECRUITINGCalgary, Alberta, T2N 5G2, Canada
-
BCCA - Vancouver
NOT_YET_RECRUITINGVancouver, British Columbia, V5Z 4E6, Canada
-
CHUM-Centre Hospitalier de l'Universite de Montreal
RECRUITINGMontreal, Quebec, H2X 3E4, Canada
-
CancerCare Manitoba
RECRUITINGWinnipeg, Manitoba, R3E 0V9, Canada
-
Cross Cancer Institute
RECRUITINGEdmonton, Alberta, T6G 1Z2, Canada
-
Hotel-Dieu de Quebec
RECRUITINGQuébec, Quebec, G1R 2J6, Canada
-
Odette Cancer Centre
RECRUITINGToronto, Ontario, M4N 3M5, Canada
-
Ottawa Hospital Research Institute
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
-
University Health Network
RECRUITINGToronto, Ontario, M5G 2M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Promising new combo targets tough head and neck cancer
- AI-Designed mRNA vaccine takes on advanced tumors in first human test
- New drug cocktail targets Hard-to-Treat cancers
- Morning vs. afternoon: can timing boost cancer immunotherapy?
- New chemo cocktail aims to tame advanced head and neck cancer
- MRNA vaccine takes on Hard-to-Treat cancers in early trial